Ivan Kairatov is a distinguished figure in the biopharma and medical technology sectors, possessing a wealth of experience in research and development that bridges the gap between laboratory innovation and clinical application. His deep understanding of how technological advancements can be integrated into high-stakes environments makes him a primary voice in the discussion surrounding the future of surgical safety. In this interview, we explore the implications of a groundbreaking patent held by Wayne State University and RediMinds Inc., which addresses the critical dangers of intraoperative bleeding. We delve into the mechanics of using computer vision and machine learning to combat the “red out” phenomenon, the practicalities of retrofitting thousands of existing surgical systems, and the broader societal benefits of reducing hospital stays and treatment costs through intelligent safety tools.
The “red out” is often described as one of the most high-pressure scenarios a surgeon can face, where vision is suddenly lost to a wash of blood. How does this new patented technology fundamentally change the way a surgical team navigates that critical window of time?
The “red out” is a truly harrowing experience for any surgical team because, in a matter of seconds, the camera lens used in robotic or laparoscopic procedures becomes completely obscured by arterial flow. This technology, officially recognized under U.S. Patent No. 12,635,098 B2, acts as a digital lifeline by providing real-time detection and localization of these bleeding sources. Instead of the surgeon having to guess or clean the field repeatedly to find the leak, machine learning algorithms identify the exact point of the arterial rupture. By presenting these sources through augmented reality overlays, the system allows the surgeon to control the bleeding with surgical precision and speed. It essentially turns a chaotic, life-threatening emergency into a guided, manageable procedure, ensuring the surgeon never loses their bearings even when the visual field is compromised.
Could you walk us through the technical synergy required to make machine learning and augmented reality work together effectively in an environment as dynamic as an operating room?
The system developed by Dr. Abhilash K. Pandya and his team at the James and Patricia Anderson College of Engineering is a masterclass in combining complex disciplines. It leverages a surgical camera that feeds data into computer vision models trained to distinguish between various types of tissue and active arterial bleeding. Once the machine learning component identifies the source of the hemorrhage, the augmented reality layer kicks in to project a precise visual marker directly onto the surgeon’s view. This happens in real time, which is crucial because every second of delay increases the risk of poor patient outcomes or even death. This pioneering advancement ensures that the AI isn’t just a passive observer but an active guide that helps the surgeon navigate the complexities of human anatomy during a crisis.
With over 2,000 robotic systems and 7,000 laparoscopic systems already in use across the United States, how feasible is it to integrate this bleeding management tool into existing hospital infrastructure?
The beauty of this technology lies in its design as an “add-on” system, which significantly lowers the barrier for hospital adoption. Since the patent was issued on May 26, 2026, the focus has been on ensuring that these 9,000 existing platforms can be upgraded without requiring a total overhaul of expensive surgical hardware. By integrating with the current camera systems and monitors already present in operating rooms, hospitals can enhance their safety protocols without the prohibitive costs of replacing entire robotic units. This approach demonstrates a commitment to moving discoveries from the lab directly to the marketplace, as emphasized by Taunya Phillips from Wayne State. It ensures that the benefits of the research are felt immediately by surgeons in Michigan and across the country.
Beyond the immediate tactical advantages during a surgery, what are the broader economic and patient health impacts you expect to see from this innovation?
The ripple effects of reducing intraoperative bleeding are immense, starting with a significant decrease in the need for blood transfusions and the constant demand for donations. When a surgeon can precisely control a bleed, the patient’s recovery time is naturally shortened, which leads to a reduction in the length of hospital stays and a lower risk of post-operative infections. From an economic standpoint, Dean Ali Abolmaali has pointed out that these efficiencies directly translate to lower treatment costs for both the healthcare system and the patients themselves. Ultimately, we are looking at a tool that not only saves lives in the moment but also improves the long-term health trajectory of anyone undergoing minimally invasive surgery. It pushes the frontier of what we consider a “safe” surgery by adding a layer of intelligent protection that was previously unavailable.
Looking at the trajectory of Dr. Pandya’s research, how do you see this patent shaping the role of artificial intelligence as a long-term partner in the operating room?
This patent represents a foundational step toward a future where AI serves as a “watchful partner” rather than just a secondary tool. As the technology matures, we expect it to monitor a vast array of variables, including patient condition, surgeon fatigue, and environmental factors, all while providing timely warnings to prevent injury. The goal is to create a proactive support system that can sense a problem before the surgeon even realizes it is developing. By securing this intellectual property, Wayne State University is ensuring that AI-assisted robotic surgery becomes a standard of care that prioritizes human safety above all else. It’s an exciting era where engineering research is being directly transformed into transformative tools for global health.
What is your forecast for AI-assisted surgical safety?
I believe we are entering a decade where the “unassisted” surgeon will become a thing of the past, as intelligent systems become as standard as the scalpel itself. Within the next few years, the integration of real-time monitoring for things like arterial bleeding will prove so effective that it will be a mandatory safety requirement for robotic systems. We will see AI move beyond simple detection into predictive modeling, where the system can warn a surgeon about potential bleeding risks based on a patient’s specific vascular structure before the first incision is even made. As these tools reduce complications and hospital stays, the data will show such a dramatic improvement in patient safety that insurance and hospital boards will make these add-on systems a universal standard. It is a transformative time where the synergy of engineering and medicine will finally eliminate the most common “preventable” errors in the operating room.
